To understand the full implication of these results, it is important to bear in mind the specific cumulative metabolic burden of type 2 diabetes, fasting plasma glucose and fasting insulin levels, dyslipidemia and metabolic syndrome. The gene discussed is INS; the disease is type 2 diabetes mellitus.